CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to OTSKF

EB-1020 (Centanafadine) high dose

Phase 3
OTSUKA (OTSKF)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Attention-Deficit Hyperactivity Disorder(ADHD)

View Full Landscape
Drug Information

Target Indication

Attention-Deficit Hyperactivity Disorder(ADHD)

Clinical Trial

NCT07086313

Last updated: 12/24/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.